All News

2020

January

Media Release / Jan 31, 2020

Sandoz completes acquisition of Aspen’s Japanese operations, strengthening its position in world’s third largest market for generics and off-patent medicines

Read More
Media Release / Jan 30, 2020

Sandoz officially recognized as Global Top Employer 2020

Read More
Media Release / Jan 29, 2020

Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019

Read More
2019

November

Media Release / Nov 12, 2019

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment

Read More
Media Release / Nov 11, 2019

Sandoz announces agreement to acquire Aspen’s Japanese operations and associated assets, strengthening position in world’s third largest generics market

Read More
Media Release / Nov 05, 2019

Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar ZiextenzoTM (pegfilgrastim-bmez)

Read More

October

Media Release / Oct 22, 2019

Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US

Read More

September

Media Release / Sep 03, 2019

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine

Read More

August

Media Release / Aug 09, 2019

Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi® (etanercept-szzs) US patent case

Read More

July

Media Release / Jul 22, 2019

Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis

Read More